Connexin-43 Restoration Alleviates Desmosomal Arrhythmogenic Cardiomyopathy
Jing Zhang1, Fabian Zanella1, Matthew W Ellis1
1Department of Medicine (J.Z., F.Z., M.W.E., W.H.B., E.J.G.-L., T.-M.W., K.F., C.D., R.C.L., V.M., Y.G., K.L.P., F.S.), University of California San Diego, La Jolla.
Circulation. Heart Failure
|January 26, 2026
Summary
Gene therapy restoring connexin-43 (Cx43) effectively treated arrhythmogenic cardiomyopathy (ACM) in preclinical models. This mutation-agnostic approach offers a potential treatment for diverse ACM populations by targeting Cx43
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Medicine
Background:
- Arrhythmogenic cardiomyopathy (ACM) is a fatal genetic heart disease caused by desmosomal gene mutations.
- Reduced connexin-43 (Cx43) expression is a common molecular defect in ACM, leading to arrhythmias.
- Current therapies for ACM are limited, especially for genetically diverse patient groups.
Purpose of the Study:
- To investigate if restoring Cx43 expression can serve as a mutation-agnostic therapeutic strategy for ACM.
- To evaluate the efficacy of adeno-associated-viral-mediated Cx43 gene therapy in preclinical ACM models.
Main Methods:
- Adeno-associated-viral-mediated gene therapy was used to restore Cx43 in mouse and human stem cell models of ACM.
- Models included mutations in desmoplakin (Dsp), plakophilin-2 (PKP2), and desmoglein-2 (DSG2).
Main Results:
- AAV-Cx43 gene therapy improved cardiac function, reduced arrhythmias, and prolonged survival in desmosomal ACM mouse models.
- Restoration of Cx43 alleviated physiological deficits in human ACM cardiomyocytes with PKP2 and DSG2 mutations.
- Mechanistically, Cx43 improved desmosomal protein stability and cell-cell coupling.
Conclusions:
- Cx43 gene therapy is sufficient to ameliorate ACM deficits across different genetic backgrounds.
- Cx43's noncanonical functions in mechanical modulation and desmosome reassembly present a therapeutic target for diverse ACM populations.
Related Concept Videos
Desmosomes
7.5K
The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein...
7.5K
Restorative Care
2.4K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
459
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
459
Cardiomyopathy II: Dilated Cardiomyopathy
531
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
531
Cardiomyopathy IV: Restrictive Cardiomyopathy
507
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
507
Cardiomyopathy V: Interprofessional Care
384
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
384


